|
HS Code |
150937 |
| Chemical Formula | C12H21NO5 |
| Molecular Weight | 259.30 |
| Appearance | Solid (usually white or off - white) |
| Physical State At Room Temperature | Solid |
| Melting Point | Specific value would require experimental determination |
| Boiling Point | Specific value would require experimental determination |
| Solubility In Water | Limited solubility |
| Solubility In Organic Solvents | Soluble in some organic solvents like dichloromethane |
| Chirality | Chiral molecule with (2R,4R) configuration |
| Functional Groups | Ester, hydroxyl, pyrrolidine ring |
As an accredited 1-Tert-Butyl 2-Methyl (2R,4R)-4-Hydroxypyrrolidine-1,2-Dicarboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100 - gram vial packaging for 1 - Tert - Butyl 2 - Methyl (2R,4R)-4 - Hydroxypyrrolidine - 1,2 - Dicarboxylate. |
| Shipping | The chemical 1 - Tert - Butyl 2 - Methyl (2R,4R)-4 - Hydroxypyrrolidine - 1,2 - Dicarboxylate will be shipped in containers suitable for chemicals. Packaging ensures protection from external factors, with proper labeling for safe and compliant transportation. |
| Storage | Store "1-Tert-Butyl 2-Methyl (2R,4R)-4-Hydroxypyrrolidine-1,2-Dicarboxylate" in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially degrade the chemical. Avoid storing near sources of heat or incompatible substances. |
|
Manufacture of macrocyclic acylsulfonamide protease inhibitors for hepatitis C virological control relies on the stereochemically pure (2R,4R)-4-hydroxyproline backbone as a conformational anchor. 1-tert-Butyl 2-methyl (2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate is charged into solution-phase amide bond formations under strictly anhydrous conditions, typically at a scale of 8–120 kg per campaign. An equimolar ratio of the pyrrolidine nitrogen to the incoming carboxy-activated quinoline or isoindoline fragment is maintained, with the hydroxyl at C4 left unprotected to serve as a subsequent nucleophilic handle for etherification or Mitsunobu inversion only after the macrocyclization step has been completed. Process deviations observed on multi-tonne stainless-steel reactors (glass-lined, 3,000 L nominal volume) include a temperature rise exceeding 5°C during HATU-mediated activation, which, if left uncontrolled, increases C2 epimerisation from <0.3% as determined by chiral HPLC (column: CHIRALPAK IA-3, mobile phase: n-hexane/EtOH/90/10 v/v, detection 210 nm) to >1.8%, breaching the ICH Q3A reporting threshold for unspecified impurities in a new drug substance. The isolated intermediate is routinely dried in a double-cone rotary vacuum dryer at 40°C and <10 mbar until loss on drying is <0.5%, as residual DMF or NMP above 2,500 ppm poisons downstream palladium-catalysed macrocyclisation. Final active pharmaceutical ingredient produced from this intermediate must meet USP monograph limits for related compounds by HPLC and residual solvents by headspace GC per USP <467>. What Process Conditions Minimise Epimerisation at C2 During SPPS Incorporation?When the Fmoc-protected analogue derived from this pyrrolidine dicarboxylate is coupled on a low-loading (0.3–0.6 mmol/g) Wang resin in automated continuous-flow peptide synthesisers, epimerisation of the urethane-activated C2 carboxylate is the primary critical quality attribute. Pre-activation with HCTU (0.95 eq.) and 2,4,6-collidine (2.0 eq.) in DMF at 0°C for 90 seconds before in-line transfer to a temperature-controlled column reactor (PFA tubing, 1.0 mm ID, 40°C jacket) suppresses D-amino acid formation to <0.15% as quantified by LC-MS after resin cleavage and Marfey’s reagent derivatisation (ASTM D8342-21 for amino acid analysis in biopharmaceuticals). A jacketed segmented-flow protocol using a Uniqsis FlowSyn Maxi™ system with back-pressure regulation at 5 bar yields crude peptide purity exceeding 94% without preparative HPLC when the coupling cycle is limited to 6 minutes and resin-bound free amine content is monitored by inline UV at 304 nm (Fmoc deprotection). Post-synthesis, the tert-butyl carbamate is removed with a cocktail of TFA/TIS/H2O (95/2.5/2.5 v/v/v) without affecting the methyl ester, which remains intact for subsequent saponification. This methodology finds application in constrained arginine-glycine-aspartic acid cyclic peptides evaluated for integrin αvβ3 targeting, where the scaffold’s 4R hydroxyl improves aqueous solubility by 1.2 log units relative to the des-hydroxy analogue. Post-Polymerisation Degradation Rate in Absorbable Polyester-Co-Ether ElastomersRing-opening terpolymerization of ε-caprolactone, p-dioxanone, and the bis-lactide derived from 1-tert-butyl 2-methyl (2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate is conducted in a 100 mL glass pressure reactor with mechanical stirring at 140°C under nitrogen blanket, using tin(II) 2-ethylhexanoate at 0.15 mol% as initiator. The protected pyrrolidine monomer is introduced at 2.5–5.0 wt%; higher loadings produce melt viscosities incompatible with filament extrusion for fused deposition modelling (FDM). Monofilament extruded through a 0.4 mm nozzle at 175°C onto a 60°C build plate in a BCN3D Epsilon W50 printer shows interlayer adhesion strength of 42 MPa in tensile mode (ISO 527-2:2012, type 5B specimen) with no delamination after accelerated hydrolytic ageing in phosphate-buffered saline at 50°C for 14 days. The pyrrolidine unit’s pendant methyl ester undergoes gradual hydrolysis to the carboxylic acid, catalysing bulk degradation; mass loss reaches 18% at 28 days versus 6% for the homopolymer control, placing the material within the degradation envelope suitable for temporary tissue fixation plates evaluated under ISO 10993-13:2010 for identification and quantification of degradation products from polymeric medical devices. Pre-drying of the monomer at 30°C and <5 mbar for 48 h is mandatory when ambient relative humidity exceeds 60%, as water-initiated oligomer formation prematurely increases polydispersity from the typical 1.4 to 2.1. The hydrochloride salt of the free amine, obtained after quantitative Boc-deprotection with 4 M HCl in dioxane, serves as a chromatographic derivatisation agent for the determination of trace aldehydes in recycled polyethylene terephthalate (rPET) destined for food-contact articles. Post-column online derivatisation HPLC with fluorescence detection (excitation 254 nm, emission 460 nm) achieves a quantification limit of 0.05 μg/L for formaldehyde and acetaldehyde, meeting the specific migration limits set in Commission Regulation (EU) No 10/2011, Annex I. The derivatisation is performed in a PEEK reaction coil at 90°C with a residence time of 45 s; the amine reagent is delivered at 0.1 mL/min into a post-column stream buffered at pH 9.5 with borate. Mixed-mode retention on a Waters XSelect™ HSS T3 column (2.5 μm, 4.6 × 150 mm) separates the hydrazone adducts in under 12 min. This analytical configuration is integrated into a quality control protocol referencing ASTM D7577-12 (Standard Test Method for Determining the Presence of Formaldehyde in Recycled Poly(ethylene terephthalate)) but improves sensitivity by a factor of 15 due to the rigid proline-like fluorophore core. Reagent stability in solution is limited to 72 h at 4°C under argon; beyond this window, peak tailing rises above USP tailing factor 2.0. Switching from tert-Butyl Dimethylsilyl to this Orthogonally Protected Core in Natural Product Total SynthesisA six-step sequence to (+)‐lactacystin employed this bis-protected hydroxyproline to circumvent the silyl migration observed when TBS ethers are carried through a lithium naphthalenide reduction. The methyl ester was chemoselectively reduced with LiBH4 (2.2 eq.) in THF at −10°C while the Boc group kept the pyrrolidine nitrogen inert; work-up with saturated Rochelle salt and extraction with EtOAc gave the primary alcohol in 89% isolated yield. Mesylation (1.05 eq. MsCl, Et3N 1.5 eq., CH2Cl2, 0°C) followed by intramolecular displacement with 0.8 M tetra-n-butylammonium azide in toluene at 60°C yielded the aziridine precursor without competitive elimination, a path previously marred by 15–20% of dihydropyrrole formation when acyclic hydroxyproline derivatives were used. The C4 hydroxyl remained untouched throughout, enabling a late-stage Dess-Martin periodinane oxidation to an α-keto amide under standard conditions ( 1.1 eq. DMP, wet CH2Cl2, 0°C to room temperature, 45 min). The overall sequence was executed on a 7 g laboratory scale with a final product enantiomeric excess of >99.9% by SFC (Chiralpak AD-H, CO2/MeOH 80/20, 3 mL/min, 40°C column oven). Industrial preparative potential is constrained by azide handling at scale; alternative routes substituting azide with N-Boc-hydroxylamine under Mitsunobu conditions are under evaluation but have not yet matched the yield profile.
OH-Directed Hydroboration Gives an All-Cis-substituted Pyrrolidine Building BlockSyn-stereochemistry of the C4 hydroxyl relative to the C2 carboxyl in this compound enables a substrate-directed hydroboration-oxidation sequence on the derived 4-methylene analogue. One-pot generation of the exocyclic olefin via the Grieco–Sharpless protocol (selenide formation, 2.0 eq. o-NO2C6H4SeCN, Bu3P 2.1 eq., THF, 0°C; oxidation with 30% H2O2 at 25°C) gives a single allylic alcohol stereoisomer after 9-BBN reduction followed by NaOH/H2O2 work-up. The resultant 3,4-cis diol is isolated after chromatography in 72% yield over three steps and used as a common intermediate for functionalized azasugars screened as glucocerebrosidase inhibitors. Enzyme inhibition assays conducted in accordance with the NIH Chemical Genomics Center protocol at 10 µM compound concentration reveal an IC50 of 280 nM for the hydrochloride salt of the free tetraol against recombinant human glucocerebrosidase (GCase) at pH 5.2. Manufacturing-scale process safety assessment is required because the selenoxide elimination step generates o-nitrobenzeneselenenic acid, which must be reduced on-line with ascorbic acid to avoid respiratory sensitiser carry-through into the drug substance.
|
Competitive 1-Tert-Butyl 2-Methyl (2R,4R)-4-Hydroxypyrrolidine-1,2-Dicarboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
1-tert-Butyl 2-methyl (2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate enters the chiral building-block inventory as a differentially protected, cis-configured hydroxyproline diester. The molecular formula C₁₁H₁₉NO₅ corresponds to a formula weight of 245.27 g/mol. The crystalline solid, obtained as a white to off-white powder, melts over the range 82–86 °C (DSC, 10 K/min, nitrogen) and exhibits a specific optical rotation typically reported between −35° and −45° (c=1, methanol, 589 nm, 20 °C). The N-terminal tert-butoxycarbonyl (Boc) group and the C-terminal methyl ester are orthogonal: the Boc moiety withstands saponification conditions that cleave the methyl ester, while the methyl ester survives acidic cleavage of the carbamate. This orthogonality permits sequential elaboration of the pyrrolidine ring without protective-group crossover, a feature that proves decisive during convergent assembly of peptidomimetic macrocycles.
Shipment and long-term storage conditions are governed by the compound’s moderate hygroscopicity and thermal lability. Dynamic vapor sorption measurements confirm that water uptake surpasses 0.5% w/w after 2 h at 25 °C / 60% RH. Consequently, the product is packaged under argon in double-lined polyethylene containers and maintained at 2–8 °C. Thermal gravimetric analysis–differential scanning calorimetry shows onset of exothermic Boc-group decomposition near 120 °C. Handling protocols therefore preclude drying above 40 °C under vacuum. When dissolution in anhydrous aprotic solvents is required immediately before use, molecular sieves (3 Å) are added to suppress ester hydrolysis. Long-term stability studies conducted under ICH Q1A(R2) conditions indicate <0.2% increase in related substances after 12 months at −20 °C.
Chiral pool-derived proline esters typically exhibit the 2S configuration, reflecting their origin from L-proline or L-hydroxyproline. The 2R,4R stereochemistry assembled here inverts the α-carbon center and places the C4 hydroxyl cis to the C2 carboxylate: that is, both substituents project from the same face of the pyrrolidine envelope. This cis relationship forces the heterocycle into a distinct puckering mode—predominantly a γ-turn-exo conformation—that alters the trajectory of the exocyclic oxygen and the carboxylate by approximately 60° relative to the trans-(2S,4R) diastereomer. The geometry directly impacts β-turn nucleation in solid-phase peptide synthesis (SPPS). Contrasted with the widely stocked (2S,4R)-N-Boc-4-hydroxyproline methyl ester, the (2R,4R) isomer is not harvested via fermentation; its supply chain relies on asymmetric hydrogenation of substituted pyrrole precursors or stereospecific enzymatic resolution, often employing lipase-mediated transesterification in vinyl acetate. Those chemoenzymatic routes add cost but yield enantiomeric excess values routinely exceeding 99.5% ee.
Batch-release analytics combine pharmacopoeial and validated in-house procedures. Liquid chromatographic purity is determined on a reversed-phase C18 column (150 × 4.6 mm, 3 µm) with gradient elution of acetonitrile in 0.1% aqueous phosphoric acid, detection at 210 nm. Enantiomeric excess is quantified by normal-phase HPLC on a polysaccharide-based chiral stationary phase (Chiralpak IA, 250 × 4.6 mm) using a 90:10 heptane:ethanol mobile phase; the (2S,4S) enantiomer elutes as the resolved minor peak. Trace water is measured by coulometric Karl Fischer titration per USP 〈921〉 Method Ic. Residual solvents are screened by headspace gas chromatography–flame ionization detection following USP 〈467〉 Procedure A. Heavy metals are reported from an inductively coupled plasma–mass spectrometry panel aligned with ICH Q3D Option 1.
| Parameter | Limit | Method Reference |
|---|---|---|
| Appearance | White to off-white crystalline powder | Visual / Ph. Eur. 2.2.1 |
| Assay (HPLC, anhydrous basis) | ≥98.0% area | Ph. Eur. 2.2.29 (modified) |
| Enantiomeric excess | ≥99.0% ee | Chiral HPLC (Chiralpak IA) |
| Water content | ≤0.5% w/w | USP 〈921〉 Method Ic |
| Residue on ignition | ≤0.1% | Ph. Eur. 2.4.14 |
| Residual acetonitrile | ≤410 ppm | USP 〈467〉 Procedure A |
| Residual methanol | ≤3000 ppm | |
| Residual dichloromethane | ≤600 ppm | |
| Lead | ≤5 ppm | ICH Q3D Option 1 |
| Cadmium | ≤2 ppm | |
| Arsenic | ≤1.5 ppm |
Stored under the specified conditions, the product maintains these specifications for the labeled shelf life of 24 months from the date of manufacture. Retest periods may be abbreviated to 6 months when the material is exposed to sustained relative humidity above 65% during dispensing.
The compound’s primary synthetic utility arises in the construction of macrocyclic peptidomimetics—particularly inhibitors of the hepatitis C virus NS3/4A protease—where the pyrrolidine ring serves as a proline surrogate carrying a defined hydroxyl orientation. The Boc group is removed on-resin with 30% trifluoroacetic acid in dichloromethane containing 2.5% triisopropylsilane over 30 min without detectable cleavage of the 2-chlorotrityl ester linker. The free secondary amine is then acylated with a quinoline- or isoquinoline-based carboxylic acid using HATU and N,N-diisopropylethylamine in dimethylformamide. The methyl ester is saponified with lithium hydroxide in THF:water (3:1) at 0 °C to liberate the C2 carboxylate, which is subsequently coupled to the N-terminus of the growing peptide chain after on-resin lactamization. The C4 hydroxyl can be temporarily silylated with tert-butyldimethylsilyl chloride to prevent branching or directly transformed into a methanesulfonate leaving group for SN2 displacement with nitrogen nucleophiles. Loading levels on Wang resin using symmetrical anhydride pre-activation reach 0.7–0.9 mmol/g, as determined by Fmoc release spectrophotometry.
During pilot-scale batch processing in a 20 L jacketed solid-phase reactor equipped with a bottom-fritted glass vessel, maintaining a resin bed temperature of 22 ± 1 °C is necessary to minimize racemization at the C2 centre. Agitation at 60 rpm with a pendulous paddle ensures uniform contact of the dilute (0.05 M) activated ester solution. Crude cleavage cocktails containing triisopropylsilane and water quench residual carbocation species, yielding the deprotected linear peptide in 45–55% crude purity before preparative HPLC purification with a C8 column and 0.1% methanesulfonic acid / acetonitrile eluent system.
The cis orientation of the C4 oxygen atom with respect to C2 imposes a sharper dihedral angle across the φ/ψ space of the pyrrolidine ring, favouring a type VI β-turn geometry that places the isopropyl side chain of an adjacent valine residue into the correct hydrophobic pocket of the protease active site. In vitro inhibition data for a model NS3/4A construct indicate that the (2R,4R) isomer raises the IC50 ratio relative to the (2S,4R) trans isomer by a factor of 8–12, attributable to loss of the hydrogen bond between the C4 hydroxyl and the backbone carbonyl of Asp168 when the hydroxyl group is positioned on the opposite face. Conversely, the (2R,4S) and (2S,4S) diastereomers produce inactive macrocycles whose cyclization yield drops below 5% under standard 10 mM high-dilution conditions (pseudodilution on-resin). This sharp structure–activity relationship drives demand for the (2R,4R) stereoisomer in medicinal chemistry campaigns.
| Property | (2R,4R) [cis] | (2S,4R) [trans] | (2R,4S) [trans] |
|---|---|---|---|
| Optical rotation [α]D20 (c=1, MeOH) | −39° ± 4° | −58° ± 5° | +55° ± 5° |
| Melting onset (DSC, peak) | 82–86 °C | 96–100 °C | 94–98 °C |
| Chiral HPLC retention factor (k′) on IA | 3.2 | 4.8 | 1.9 |
| β-turn mimic efficacy (IC50 model protease) | High (reference) | 8–12× weaker | Negligible |
| Solid-phase coupling yield (HATU/DIPEA) | 88–92% | 82–86% | 70–75% |
| Aqueous solubility (pH 6.8, 25 °C) | 0.45 mg/mL | 0.60 mg/mL | 0.52 mg/mL |
The differential aqueous solubility profile impacts workup during methyl ester hydrolysis: phase separation using ethyl acetate extraction leaves the (2R,4R) carboxylic acid preferentially in the organic layer, reducing the need for repetitive back-extraction. Scale-up campaigns that require multi-kilogram quantities therefore select the (2R,4R) cis isomer not only for bioactivity but also for process mass intensity advantages. Substitution at nitrogen with bulkier carbamates—such as 9-fluorenylmethoxycarbonyl (Fmoc)—is poorly tolerated in the cis series because of steric compression between the Fmoc ring system and the C4 hydroxyl; use of the Fmoc analogue is not recommended when coupling requires a free C4 hydroxyl for downstream functionalization. Alternative N-protection with benzyloxycarbonyl (Cbz) is feasible but requires catalytic hydrogenolysis, which is incompatible with substrates containing aryl halides used in later Suzuki couplings. No published data support replacement of the methyl ester with a benzyl ester for applications demanding simultaneous deprotection of both carboxyl and side-chain protecting groups.